{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:51:20Z","timestamp":1792194680086,"version":"4.4.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Hepatitis B and C are viral infections causing chronic liver inflammation and, when left untreated, lead to cirrhosis and a risk for hepatocellular carcinoma, the most common type of primary liver cancer with high mortality. The hepatitis B virus-hepatitis C virus (HBV-HCV) coinfection leads to a faster progression to advanced liver diseases and higher hepatocellular carcinoma (HCC) risk than monoinfection. Unlike the relative risk for HCC due to either HBV or HCV, no recent analysis of the risk for HBV-HCV coinfection exists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Based on PRISMA recommendations and guidelines, we developed a search strategy by combining the keywords (\u201chepatitis B\u201d) and (\u201chepatitis C\u201d) and (\u201chepatocellular carcinoma\u201d or \u201cliver cancer\u201d). First, we performed a title and abstract screening and, later, a full-text screening. We extracted the demographic characteristics, such as gender, age, study design, sample size, country, and biomarkers of hepatitis B surface antigen (HBsAg), HBV DNA, HBeAg, anti-HCV, and HCV RNA. The data were assessed for quality, and the Review Manager software was used for the meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We included 63 studies. The pooled analysis showed that the risk of HCC was significantly higher in the case-cohort who were positive for HBsAg (odds ratio [OR] = 9.70 [3.75, 25.12],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), HBV DNA or HBeAg (OR = 22.77 [10.00, 51.88],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), HBV and HCV coinfection (OR = 46.07 [26.33, 80.60],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001) than the control cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Chronic HBV and HCV infections are major risk factors for HCC, and their coinfection was significantly associated with an increased risk of HCC than monoinfection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jgid.jgid_211_23","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T14:00:25Z","timestamp":1734789625000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis"],"prefix":"10.4103","volume":"16","author":[{"given":"Abdullah A.","family":"Awadh","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Alharthi","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil A.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraj T.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K.","family":"Baqays","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim S.","family":"Binrabaa","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa A.","family":"Malli","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"R2-20241221","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3350\/cmh.2021.0171","article-title":"Hepatocellular carcinoma statistics in South Korea","volume":"27","author":"Chon","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"R3-20241221","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"R4-20241221","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"R5-20241221","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.27743","article-title":"Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)","volume":"62","author":"Trinchet","year":"2015","journal-title":"Hepatology"},{"key":"R6-20241221","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the Global Burden of Disease Study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"R7-20241221","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","article-title":"Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis","volume":"23","author":"Kew","year":"2003","journal-title":"Liver Int"},{"key":"R8-20241221","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores","volume":"157","author":"Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"R9-20241221","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrgastro.2016.140","article-title":"Effect of HCV clearance with direct-acting antiviral agents on HCC","volume":"13","author":"Llovet","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R12-20241221","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/apt.15976","article-title":"Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination","volume":"52","author":"Ogawa","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-20241221","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4254\/wjh.v3.i1.24","article-title":"First multicenter study for risk factors for hepatocellular carcinoma development in North Africa","volume":"3","author":"Bahri","year":"2011","journal-title":"World J Hepatol"},{"key":"R14-20241221","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.21608\/ejhm.2022.244534","article-title":"Recurrence of Hepatocellular Carcinoma in Hepatitis (C) Virus Related Cirrhosis Treated with Direct Acting Antiviral Therapy","volume":"88","author":"El-Ghoneimy","year":"2022","journal-title":"The Egyptian Journal of Hospital Medicine"},{"key":"R15-20241221","doi-asserted-by":"crossref","first-page":"43","DOI":"10.20517\/2394-5079.2018.26","article-title":"Factors predicting hepatocellular carcinoma in hepatitis C infection","volume":"4","author":"Abbas","year":"2018","journal-title":"Hepatoma Research"},{"key":"R16-20241221","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jfma.2019.09.006","article-title":"Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?","volume":"119","author":"Hsu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"R18-20241221","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/biomedicines8060175","article-title":"Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals","volume":"8","author":"Kishta","year":"2020","journal-title":"Biomedicines"},{"key":"R19-20241221","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/jnc.14616","article-title":"Genetic and epigenetic contribution to astrocytic gliomas pathogenesis","volume":"148","author":"Khani","year":"2019","journal-title":"J Neurochem"},{"key":"R20-20241221","first-page":"2531","article-title":"Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells","volume":"51","author":"Li","year":"1991","journal-title":"Cancer Res"},{"issue":"Suppl 13","key":"R21-20241221","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1158\/1538-7445.AM2017-5441","article-title":"Abstract 5441: Circulating exosomal microRNA-203 and microRNA-373 as non-invasive biomarkers for predicting prognosis and metastasis in human hepatocellular carcinoma","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res"},{"key":"R22-20241221","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1002\/jcp.27956","article-title":"MicroRNAs: Key players in virus-associated hepatocellular carcinoma","volume":"234","author":"Sadri","year":"2019","journal-title":"J Cell Physiol"},{"key":"R23-20241221","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3736\/jcim20090918","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (Chinese edition)","volume":"7","author":"Moher","year":"2009","journal-title":"J Chin Integr Med"},{"key":"R27-20241221","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.25321","article-title":"Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta-analysis","volume":"128","author":"Cho","year":"2011","journal-title":"Int J Cancer"},{"key":"R28-20241221","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/165.5.831","article-title":"Role of hepatitis c virus infection in spontaneous hepatitis b surface antigen clearance during chronic hepatitis b virus infection","volume":"165","author":"Shyan","year":"1992","journal-title":"J Infect Dis"},{"key":"R29-20241221","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/JCM.36.7.2084-2086.1998","article-title":"Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection","volume":"36","author":"Chu","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R30-20241221","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/jvh.13099","article-title":"Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term","volume":"26","author":"Haga","year":"2019","journal-title":"J Viral Hepat"},{"key":"R31-20241221","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/hep.27337","article-title":"Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients","volume":"60","author":"Kruse","year":"2014","journal-title":"Hepatology"},{"key":"R32-20241221","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/jvh.12723","article-title":"Higher risk of hepatocellular carcinoma in chronic hepatitis B versus chronic hepatitis C after achievement of virologic response","volume":"24","author":"Kim","year":"2017","journal-title":"J Viral Hepat"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_211_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:49Z","timestamp":1787068069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_211_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jgid.jgid_211_23","relation":{},"ISSN":["0974-777X","0974-8245"],"issn-type":[{"value":"0974-777X","type":"print"},{"value":"0974-8245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2023-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}